Location History:
- Dublin 7, IE (2012)
- Dublin, IE (2006 - 2019)
Company Filing History:
2 out of 4 
2 out of 2 
1 out of 1 Years Active: 2006-2019
Title: Paul Kenna: Innovator in Gene Therapy and Mitochondrial Research
Introduction
Paul Kenna is a notable inventor based in Dublin, Ireland, recognized for his significant contributions to the fields of gene therapy and mitochondrial research. With a total of five patents to his name, Kenna has been at the forefront of innovative solutions aimed at addressing critical health challenges associated with mitochondrial dysfunction.
Latest Patents
Among his latest patents, two stand out for their potential to transform treatment methodologies. The first patent focuses on variants of the yeast NDI1 gene, describing an isolated nucleic acid sequence that encodes the yeast NDI1 protein or its functional variants. This sequence is noteworthy for its codon optimization, comprising at least 50 codons compared to the traditional yeast NDI1 gene sequence. This advancement could lead to novel treatments for diseases linked to mitochondrial dysfunction.
The second patent relates to the enhancement of gene suppression and replacement through the use of conserved regions of the rhodopsin gene in a viral vector. This invention aims to improve the expression of suppression agents that inhibit gene expression and ensure the efficacy of replacement nucleic acids by mitigating the effects of the suppression agents. Such innovations hold promise for advancements in genetic therapies.
Career Highlights
Throughout his career, Paul Kenna has worked with esteemed institutions including the Provost, Fellows, and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth and Optigen Patents Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development in his field.
Collaborations
Kenna has collaborated with several notable professionals, including Peter Humphries and Gwyneth Jane Farrar. These collaborations have further enriched his research endeavors, fostering a dynamic exchange of ideas and expertise.
Conclusion
In summary, Paul Kenna stands out as a distinguished inventor with a clear focus on innovations in gene therapy and mitochondrial health. His patented inventions not only illustrate his commitment to advancing science but also hold the potential to significantly impact medical treatment strategies in the future. As he continues to push the boundaries of research, the scientific community eagerly anticipates his future contributions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.